Finance

Lists
LUNA:VIE
H Lundbeck A/S Class A
6,92 €
+1,17%
(+0,080) 1D
6-ноя., 17:36:00 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for LUNA...
Open
6,75 €
High
6,92 €
Low
6,75 €
Mkt. cap
54,49 млд
Avg. vol.
85,00
Volume
0,00
52-wk high
6,92 €
52-wk low
4,22 €
No. of employees
5 миң
Open
6,75 €
High
6,92 €
Low
6,75 €
Mkt. cap
54,49 млд
Avg. vol.
85,00
Volume
0,00
52-wk high
6,92 €
52-wk low
4,22 €
No. of employees
5 миң
News stories
From web sources and news partners
Profile
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
About H Lundbeck A/S Class A
CEOCharl Van Zyl
Employees5 миң
Founded1915
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in DKK
Loading Previous Earnings...
Revenue
Net income
All values in DKK
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
6,28 млд
6,09 млд
7,12 млд
6,46 млд
Cost of goods sold
846,00 млн
1,24 млд
1,30 млд
1,27 млд
Cost of revenue
846,00 млн
1,24 млд
1,30 млд
1,27 млд
Research and development expenses
1,16 млд
820,00 млн
1,38 млд
1,43 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,15 млд
2,54 млд
2,13 млд
2,28 млд
Operating expense
3,31 млд
4,36 млд
3,52 млд
3,70 млд
Total operating expenses
4,16 млд
5,60 млд
4,82 млд
4,96 млд
Operating income
2,12 млд
490,00 млн
2,31 млд
1,50 млд
Other non operating income
-
-32,00 млн
-
-
EBT including unusual items
1,41 млд
360,00 млн
2,13 млд
1,47 млд
EBT excluding unusual items
1,90 млд
567,00 млн
2,28 млд
1,47 млд
Income tax expense
311,00 млн
387,00 млн
468,00 млн
323,00 млн
Effective tax rate
22,03%
107,50%
22,01%
21,96%
Other operating expenses
-
997,00 млн
-
-11,00 млн
Net income
1,10 млд
-27,00 млн
1,66 млд
1,15 млд
Net profit margin
17,53%
-0,44%
23,27%
17,76%
Earnings per share
1,44
0,94
2,16
1,54
Interest and investment income
-
199,00 млн
-
-
Interest expense
-219,00 млн
-83,00 млн
-29,00 млн
-27,00 млн
Net interest expenses
-219,00 млн
116,00 млн
-29,00 млн
-27,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
2,55 млд
956,00 млн
2,78 млд
1,98 млд
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору